# UCB Pharma S.A. - Inspection Records

Source: https://www.keypedia.com/companies/ucb-pharma-sa/6a03badf-6619-4125-b598-85ceebcc8c50

> Inspection records and compliance data for UCB Pharma S.A. in Brabant Wallon, None. Access full analysis and detailed observations.

---

## Details

- Name: UCB Pharma S.A.
- FEI Number: 3003909356
- City: Brabant Wallon
- State: None
- Country Name: Belgium
- Address Line 1: Chemin Du Foriest
- Address Line 2: Braine-L'Alleud
- Zip Code: None
- Facility Type: Drug Product
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - UCB Pharma S.A. - Unknown Date](https://www.keypedia.com/records/483/ucb-pharma-sa/7634bf8a-098c-4f65-869f-8b8dc49bf228) — source: FDA, date: Invalid Date
- [FDA Inspection 1247808 - UCB Pharma S.A. - 2024-02-01](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/75bbe824-0278-4dd2-961f-3fb1dd326b03) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 1, 2024
- [483 - UCB Pharma S.A. - 2023-04-21](https://www.keypedia.com/records/483/ucb-pharma-sa/faf15e0c-4ee4-4868-84c5-48cd719f4855) — source: FDA, date: April 21, 2023
- [EIR - UCB Pharma S.A. - 2023-04-21](https://www.keypedia.com/records/eir/ucb-pharma-sa/0a4d5150-1f3d-4902-a9e3-98e6c80b367f) — source: FDA, date: April 21, 2023
- [FDA Inspection 1208307 - UCB Pharma S.A. - 2023-04-21](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/9be817f5-ce00-46cd-81a9-df3f6367f9ac) — source: FDA, date: April 21, 2023
- [483 - UCB Pharma S.A. - 2022-02-04](https://www.keypedia.com/records/483/ucb-pharma-sa/6036226d-2920-43af-9bd3-61847498eee7) — source: FDA, date: February 4, 2022
- [EIR - UCB Pharma S.A. - 2022-02-04](https://www.keypedia.com/records/eir/ucb-pharma-sa/c0412e1a-bd81-4e61-8d2c-6bc873ddb1ac) — source: FDA, date: February 4, 2022
- [483 - UCB Pharma S.A. - 2022-02-04](https://www.keypedia.com/records/483/ucb-pharma-sa/4d10a705-f62a-4e4d-a1a3-bc75539da471) — source: FDA, date: February 4, 2022
- [FDA Inspection 1170317 - UCB Pharma S.A. - 2021-11-25](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/68af8621-3056-4190-a420-b538f959b83e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 25, 2021
- [FDA Inspection 1013309 - UCB Pharma S.A. - 2017-01-27](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/b869769c-b1b8-4e08-b406-591c9e291b9f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 27, 2017
- [FDA Inspection 946302 - UCB Pharma S.A. - 2015-09-11](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/4a28d1df-64ef-4aa7-b8ac-3606f8d6b0de) — classification: No Action Indicated (NAI), source: FDA, date: September 11, 2015
- [FDA Inspection 908458 - UCB Pharma S.A. - 2014-12-16](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/761bc90e-3068-433b-a89e-881d0c63756f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 16, 2014
- [FDA Inspection 822144 - UCB Pharma S.A. - 2013-02-01](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/9add6b7a-66d2-4956-986f-a91f6f89b1ee) — classification: No Action Indicated (NAI), source: FDA, date: February 1, 2013
- [FDA Inspection 744056 - UCB Pharma S.A. - 2011-07-01](https://www.keypedia.com/records/fda_inspections/ucb-pharma-sa/9c4607f8-670e-4a9c-9b7f-73d857432d79) — classification: No Action Indicated (NAI), source: FDA, date: July 1, 2011

## Related Companies

- [Bajaj Medical, LLC](https://www.keypedia.com/companies/bajaj-medical-llc/3aea5c6c-9e94-429d-82a0-594d8f8c666e)
- [Ava Inc](https://www.keypedia.com/companies/ava-inc/2b241090-1e53-4f25-8e52-c8105395fb0b)
- [Everest Life Sciences LLC](https://www.keypedia.com/companies/everest-life-sciences-llc/3f0de21d-b48b-4f8a-a8a2-3b6e376528f4)
- [Symrise, Inc](https://www.keypedia.com/companies/symrise-inc/3c94427e-fd36-4498-bcbd-148093d778bd)
- [Cronus Pharma Specialities India Pvt Ltd](https://www.keypedia.com/companies/cronus-pharma-specialities-india-pvt-ltd/5eba515d-716e-4acb-b927-57e4973bb0c4)
- [Sandoz GmbH](https://www.keypedia.com/companies/sandoz-gmbh/02a3eaeb-a765-43ae-873b-93d1d1523696)
- [Lusomedicamenta Sociedade Tecnica Farmaceutica S.A](https://www.keypedia.com/companies/lusomedicamenta-sociedade-tecnica-farmaceutica-sa/f5b2b06c-020e-4078-9766-b6b28bc61e65)
- [Western Chemical Inc.](https://www.keypedia.com/companies/western-chemical-inc/f13bfcbc-06d5-4798-b88f-92e71ffad710)
- [Ash Stevens LLC](https://www.keypedia.com/companies/ash-stevens-llc/52224de1-83ac-4289-a4f7-7bc9f6813f03)
- [Appco Pharma LLC](https://www.keypedia.com/companies/appco-pharma-llc/b4a77ba5-0e8a-47ae-94c2-951f5a0b2100)

## Related Officers

- [investigator](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
- [National Expert, Pharmaceutical](https://www.keypedia.com/people/simone-e-pitts/e405f1fc-4aff-4202-b216-ddbdc342d108)
- [Investigator](https://www.keypedia.com/people/roger-f-zabinski/87e05838-f8b5-489a-8db7-6669e68a2c2e)
- [Senior Regulatory Specialist](https://www.keypedia.com/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)